Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The Genetics of Multiple Myeloma
1
x
$
0.00
P. Murali Doraiswamy, MD: A Randomized Controlled Trial of Paroxetine for Noncardiac Chest Pain
1
x
$
30.00
Neuropharmacology of Paroxetine
1
x
$
30.00
John P. Houston - Early Symptom Change Prediction of Remission in Depression Treatment
1
x
$
30.00
Diagnosis and Treatment of Depression in the Cancer Patient
1
x
$
0.00
Guest Editor: Research Needs in Myeloma
1
x
$
0.00
Síndrome de Interrupción del ISRS: Un nuevo problema antiguo
1
x
$
0.00
Risperidone: Review of Its Therapeutic Utility in Depression
1
x
$
30.00
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
1
x
$
30.00
View Cart
Checkout
Home
estelle-vester-blokland
“Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Page load link
Go to Top
